Southern Research announced today that it has entered into a strategic collaboration with New York-based Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, to support the development of a vaccine, TNX-1800, against the new coronavirus disease, COVID-19, based on Tonix’s proprietary horsepox vaccine platform.
Scientists at Southern Research’s Drug Discovery division have joined the fight against malaria through efforts aimed at discovering new drugs and improving the safety and efficacy of current antimalarial medicines.
Southern Research and Japan’s Ina Research announced today they have formed a partnership that calls for Ina to help connect Southern Research with potential new customers for drug development services in the country with the world’s third largest pharmaceutical industry.
Southern Research announced today that April M. Brys, Ph.D., an experienced life sciences executive with a strong track record in research and leadership roles, has been named vice president of the non-profit organization’s Drug Development division.
How certain bacteria may make people more prone to asthma is one topic of three research grants jointly funded by Southern Research and the UAB School of Medicine. These new research pilots are the latest effort to harness synergies between researchers at the University of Alabama at Birmingham and Southern Research, a Birmingham-based nonprofit research institute with nearly 400 scientists and engineers. The two other pilots seek an improved way to develop new vaccines and a new mouse model for a potentially dangerous, hereditary deficiency shared by 400 million people worldwide.
Scientists at the microbiology lab led by Javier Campos-Gómez, Ph.D., in Drug Discovery at Southern Research discovered that Pseudomonas aeruginosa, a bacterium responsible for severe, drug-resistant infections in humans, uses a family of fatty acids, known as “oxylipins,” in a cell-to-cell signaling language critical for its virulence.
Southern Research’s Stacey Kelpke, Ph.D., believes Birmingham is well equipped to become the next hub for the development of innovative medical devices, thanks to the city’s rich manufacturing heritage and its wide-ranging healthcare expertise,
Southern Research has announced the Transgenic Mouse Human PD-1/L1 Model, its newest service offering in support of immuno-oncology (IO) therapeutic development.
Engineers at Southern Research are helping NASA’s Marshall Space Flight Center explore the capabilities of additive manufacturing technologies that have major logistics implications for the nation’s ambitious future space missions.
The U.S. Department of Energy has selected Southern Research for an award of up to $1.5 million to advance technology for carbon dioxide utilization.
Southern Research has become the first organization in the United States to earn accreditation under ISO 14034, a new international standard for evaluating and verifying environmental technologies that was recently adopted by the American National Standards Institute.
Southern Research and the National Institute of Clean and Low-Carbon Energy (NICE) are collaborating on a project to transform retired electric vehicle batteries into energy storage systems for offices and factories.
Stacey S. Kelpke, Ph.D., an experienced biomedical/bioengineering researcher, has been named program manager of Southern Research's medical device technologies initiative, AIMTech.
Southern Research announced today that accomplished researcher Dr. Babu L. Tekwani has joined the Birmingham-based organization as Distinguished Fellow and Chair of the Infectious Disease Department in Drug Discovery.
Kazutoshi (Kazu) Nakazawa, M.D., Ph.D., whose work has explored how abnormalities in brain circuitry can trigger complex mental disorders, has joined the Southern Research's Neuroscience Department as a Fellow.
Southern Research’s Prosperity Fund is assisting an Alabama startup that sees one of nature’s great recyclers – the black soldier fly – as an instrument to convert chicken poop into high-value products such as protein-rich animal feed and organic fertilizer.
Southern Research scientists are exploring how a mutated protein implicated in prostate cancer plays a role in the development of the disease and whether it holds a key to better treatment outcomes.
The U.S. Department of Energy (DOE) has selected Southern Research for an award of up to $5.9 million to advance production of high-performance, low-cost carbon fibers from biomass.
Southern Research scientists are working on several fronts to help limit the death toll from a catastrophic flu outbreak that one day slams the nation.
Southern Research has been selected to receive nearly $1.7 million in U.S. Department of Energy funding to develop a new, cost-efficient gasifier capable of converting low-grade coal into synthesis gas (syngas) that can be used in a number of applications.
Southern Research announced that Jay Liu, Ph.D., an experienced biotech industry innovator and entrepreneur, has joined its Drug Discovery division as director of technology development and innovation.
Business consultant and serial entrepreneur Steven Puckett has been named managing director of Southern Research’s Prosperity Fund, a $2.4 million initiative that seeks to inject economic vitality into four Alabama counties hit hard by the coal industry’s downturn.
Southern Research and Bionetix Inc., a South Korea-based biotech firm, have signed a research and license agreement to develop a new anti-cancer drug that affects a key genetic switch associated with suppression and regulation of the growth of certain types of cancer.
Southern Research and the University of Tennessee Health Science Center (UTHSC) have formed a partnership to advance promising research that could lead to new drugs that address unmet medical needs.
Southern Research today announced plans to expand the scope of its longtime educational outreach efforts with the hiring of a STEM educator to direct a statewide program.
The Southern Research-developed stabilized telescopes with sensitive, high-speed, visible-light and infrared cameras flew aboard NASA WB-57F research aircraft to gather data during the total solar eclipse.
Southern Research’s Energy & Environment division (E&E) will participate as a subcontractor to WRI to provide renewable acrylonitrile -- the key raw material needed to produce the highest quality carbon fibers -- produced from biomass-derived second generation sugars.
Southern Research has been awarded two contracts from BARDA for nonclinical research services advancing the agency’s work to protect the U.S. against infectious disease and bio-terror threats.
Rita Cowell, Ph.D., has joined the Southern Research as Chair of the Neuroscience Department as it expands research and drug discovery efforts focusing on diseases such as Parkinson’s and Alzheimer’s.
Southern Research scientist Dr. Raj Kalkeri says a new generation of antiviral therapies is urgently needed against hepatitis B, a chronic disease affecting 240 million people whose cure has proved elusive.
A high-definition imaging system developed by Southern Research and deployed on NASA aircraft flying nearly 10 miles above Earth will give scientists a unique look at the Sun’s corona during a rare total eclipse taking place over the United States in August.
Mark Patterson, Ph.D., an engineer and innovator with broad experience across a sweeping range of technology disciplines, has joined Southern Research’s Engineering Division to lead business development efforts focusing on the aerospace industry.
Southern Research scientists are investigating how the Zika virus is able to find a safe harbor in an infected host’s tissue and stage a rebound weeks after the virus was seemingly cleared by the immune system.
With backing from the Appalachian Regional Commission (ARC), Southern Research is launching The Prosperity Fund, a $2.4 million initiative to accelerate entrepreneurial activity and spark job creation in four Alabama counties rocked by the coal industry’s steep downturn.
A Southern Research team led by President and CEO Art Tipton will travel to next week’s BIO International conference for focused meetings that center on a promising pipeline of early-stage drug candidates for diseases such as Alzheimer’s, Parkinson’s, diabetes and cancer.
Two out of three cancer patients are treated with radiation, but the therapy often fails to wipe out the tumor or slow its growth. Southern Research is working to develop a new class of drugs that will help the radiation deliver a more powerful punch to the disease.
Southern Research announced today that Lillie Ryans has joined the Birmingham-based organization as director of contracts.
Southern Research is launching a new biosafety training center as the centerpiece of an advanced program called TrainSafe to teach health care workers and laboratory staff how to protect themselves against pathogens responsible for serious infectious diseases.
The Hugh Kaul Foundation is supporting Southern Research’s wide-ranging economic development efforts with a $100,000 gift.
The U.S. Department of Energy’s Office of Fossil Energy has awarded Southern Research nearly $800,000 for a project that targets a more cost-efficient and environmentally friendly method of producing some of the most important chemicals used in manufacturing.
Southern Research has been selected by NASA’s Johnson Space Center for work under a specialized engineering, aeronautic, and manufacturing (SEAM) contract to support the Houston center’s Flight Operations Directorate, which performs critical functions for the space agency.
The Robert R. Meyer Foundation is supporting Southern Research’s Drug Discovery program with a $500,000 gift that aims to accelerate efforts to find new treatments for unmet medical conditions and rare and neglected diseases.
Southern Research has hired Michael Catalano as vice president and general counsel.
Southern Research announced today that C. Ray Hayes, chancellor of the University of Alabama System, and Nancy E. Dunlap, M.D., Ph.D., an accomplished health care administrator and professional, have joined the non-profit organization’s board of directors.
Mark J. Suto, Ph.D., vice president of Drug Discovery at Southern Research, has been named a Fellow of the National Academy of Inventors (NAI) in recognition of his wide-ranging contributions to pharmaceutical research and drug discovery efforts.
An investigation by Southern Research biologists reveals for the first time that fatty acids known as oxylipins play a critical role in the formation of the biofilm shield that protects disease-causing bacteria from antibiotics.
/PRNewswire-USNewswire/ -- Southern Research has been awarded a new, five-year Indefinite-Delivery Indefinite-Quantity (IDIQ) contract from the National Cancer Institute (NCI) to investigate the pharmacokinetic properties of antitumor and other therapeutic agents of interest to the Division of Cancer Treatment and Diagnosis (DCTD) under NCI contract HHSN261201600021I. RFP number N02CM67000-11 was issued under full and open competition, which resulted in five IDIQ awards. Task orders will be competed among the five IDIQ Contractors in the award pool and placed off of the IDIQ as requirements arise.
Southern Research announced today the Alliance for Innovative Medical Technology (AIMTech) has won a $500,000 grant from the U.S. Department of Commerce to expand its proof-of-concept program.
Southern Research honored the innovative work being conducted in its laboratories and facilities with the organization’s Intellectual Property Awards, announced at a special ceremony on Oct. 25.
With the poliovirus edging closer to eradication across the globe, Southern Research’s infectious disease labs are playing a critical role in the search for a drug that could aid the ongoing worldwide polio eradication initiative and help halt the spread of the crippling disease in a future outbreak or bio-attack.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right